Presence of multiple spondyloarthritis (SpA) features is important but not sufficient for a diagnosis of axial spondyloarthritis: data from the SPondyloArthritis Caught Early (SPACE) cohort

Autor: M. van Lunteren, Mariagrazia Lorenzin, P. Bakker, Z. Ez-Zaitouni, M. van Oosterhout, D. van der Heijde, Robert Landewé, Inger Jorid Berg, F. A. van Gaalen
Přispěvatelé: AII - Inflammatory diseases, Clinical Immunology and Rheumatology
Jazyk: angličtina
Rok vydání: 2017
Předmět:
Adult
Male
Genetics and Molecular Biology (all)
0301 basic medicine
musculoskeletal diseases
medicine.medical_specialty
Immunology
Biochemistry
General Biochemistry
Genetics and Molecular Biology

Young Adult
03 medical and health sciences
0302 clinical medicine
Rheumatology
Internal medicine
Spondyloarthritis
medicine
Back pain
Humans
Immunology and Allergy
Overdiagnosis
Axial spondyloarthritis
Spondylarthropathies
HLA-B27 Antigen
030203 arthritis & rheumatology
Sacroiliac joint
business.industry
Sacroiliac Joint
Baseline data
Magnetic Resonance Imaging
Low back pain
Low Back Pain
Outcomes research
Algorithms
Back Pain
Chronic Pain
Early Diagnosis
Radiography
Biochemistry
Genetics and Molecular Biology (all)

030104 developmental biology
medicine.anatomical_structure
Cohort
Physical therapy
medicine.symptom
business
Zdroj: Annals of the rheumatic diseases, 76(6), 1086-1092. BMJ Publishing Group
Annals of the Rheumatic Diseases, 76(6), 1086-1092
ISSN: 0003-4967
1086-1092
Popis: ObjectivesConcerns have been raised about overdiagnosis of axial spondyloarthritis (axSpA). We investigated whether patients with chronic back pain (CBP) of short duration and multiple SpA features are always diagnosed with axSpA by the rheumatologist, and to what extent fulfilment of the Assessment of SpondyloArthritis International Society (ASAS) axSpA criteria is associated with an axSpA diagnosis.MethodsBaseline data from 500 patients from the SPondyloArthritis Caught Early cohort which includes patients with CBP (≥3 months, ≤2 years, onset ResultsBefore sacroiliac imaging and HLA-B27 testing, 32% of patients had ≤1 SpA feature, 29% had 2 SpA features, 16% had 3 SpA features and 24% had ≥4 SpA features. A diagnosis of axSpA was made in 250 (50%) of the patients: 24% with ≤1 SpA feature, 43% with 2 SpA features, 62% with 3 SpA features and 85% with ≥4 SpA features. Of the 230 patients with a positive ASAS classification 40 (17.4%) did not have a diagnosis of axSpA. HLA-B27 positivity (OR 5.6; 95% CI 3.7 to 8.3) and any (MRI-SI and/or X-SI) positive imaging (OR 34.3; 95% CI 17.3 to 67.7) were strong determinants of an axSpA diagnosis.ConclusionsIn this cohort of patients with CBP, neither the presence of numerous SpA features nor fulfilment of the ASAS classification criteria did automatically lead to a diagnosis axSpA. Positive imaging was considered particularly important in making a diagnosis of axSpA.
Databáze: OpenAIRE